OptimizeRx Corporation

OPRX

US68401U2042

Internet Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
10.12 ^USD	+15.00%		+8.58%	-29.28%

Apr. 16	Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	MT
Apr. 16	Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26	MT

OptimizeRx Corporation Provides Earnings Guidance for the Year 2024

November 06, 2023 at 07:00 am EST

OptimizeRx Corporation provided earnings guidance for the year 2024. For the year, the company expects revenue to be at least $110 million.

Latest news about OptimizeRx Corporation

Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	Apr. 16	MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26	Apr. 16	MT
OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024	Apr. 16	CI
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
JMP Securities Initiates Coverage on OptimizeRx With Market Perform Rating, $15 Price Target	Apr. 04	MT
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop	Apr. 01	MT
Transcript : OptimizeRx Corporation, Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.	Mar. 27	CI
OptimizeRx Corp. Powers Walmart's ?Specialty Pharmacies of the Community? Outreach Effort	Mar. 04	CI
OptimizeRx Corporation Announces Changes to its Board	Jan. 25	CI
RBC Adjusts OptimizeRx's Price Target to $17 From $14, Keeps Outperform Rating	Jan. 10	MT
OptimizeRx Shares Jump as Preliminary 2023 Revenue Tops Guidance	Jan. 09	MT
OptimizeRx Corporation Revises Earnings Guidance for the Year 2023	Jan. 09	CI
Barclays Starts OptimizeRx With Equalweight Rating, $15 Price Target	Jan. 03	MT
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.	Nov. 14	CI
Transcript : OptimizeRx Corporation, Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
OptimizeRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q3 Revenue $16.3M, vs. Street Est of $15.1M	Nov. 06	MT
OptimizeRx Corporation Provides Earnings Guidance for the Year 2024	Nov. 06	CI
OptimizeRx Corporation Increases Earnings Guidance for the Year 2023	Nov. 06	CI
North American Morning Briefing : Stocks Look to -2-	Nov. 06	DJ
OptimizeRx Corporation completed the acquisition of Healthy Offers, Inc. from a group of shareholders.	23-10-23	CI
Optimizerx Corporation to Change the Designation of Stephen L. Silvestro from Chief Commercial Officer to President	23-10-16	CI
Transcript : Healthy Offers, Inc., OptimizeRx Corporation - M&A Call	23-10-12
OptimizeRx Agrees to Acquire Medicx Health for $95 Million; Issues Q3 Non-GAAP Net Income, Revenue Expectations	23-10-12	MT

OptimizeRx Corporation is a digital health technology company, which enables engagement between life sciences organizations, healthcare providers and patients. The Company's principal solutions include evidence-based physician engagement, point of care banner messaging, social network banner messaging, institutional account-based banner messaging, financial messaging, patient engagement and therapy initiation workflow. Its evidence-based physician engagement solution uses predictive analytics via machine learning methods applied to real-world data (RWD) to assist healthcare providers (HCPs). Its point of care banner messaging solution utilizes to deliver a variety of awareness and messaging within the clinical workflow, which can be tailored to meet the needs of each brand. Its Institutional Account-based Banner Messaging solution provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts.

Sector

Internet Services

Calendar

2024-05-13 - RBC Capital Markets Global Healthcare Conference

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for OptimizeRx Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.12 USD

Average target price

16.17 USD

Spread / Average Target

+59.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Internet Services

	1st Jan change	Capi.
OPTIMIZERX CORPORATION	-29.28%	184M
TENCENT HOLDINGS LIMITED	+18.66%	414B
NETFLIX, INC.	+15.27%	242B
UBER TECHNOLOGIES, INC.	+12.15%	144B
AIRBNB, INC.	+20.63%	104B
PROSUS N.V.	+17.19%	83.87B
SPOTIFY TECHNOLOGY S.A.	+54.11%	57.64B
DOORDASH, INC.	+33.59%	53.37B
COSTAR GROUP, INC.	+6.02%	37.83B
NASPERS LIMITED	+15.88%	34.11B

Other Internet Services